Wells Fargo Reiterates Overweight Rating on Autolus Therapeutics plc (AUTL)

May 20, 2024 6:43 AM EDT Send to a Friend
Wells Fargo analyst Yanan Zhu reiterated an Overweight rating and $8.00 price target on Autolus Therapeutics plc (NASDAQ: AUTL).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login